Compare Health Care Select Sector SPDR Fund (XLV) vs Zeta Global Holdings Corp (ZETA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Health Care Select Sector SPDR Fund vs Zeta Global Holdings Corp — how do they compare? Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B), while Zeta Global Holdings Corp trades at $33.09 (market cap $8.29B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 5.2× Zeta Global Holdings Corp's market cap, and Zeta Global Holdings Corp is trading nearer its 52-week high, Health Care Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Health Care Select Sector SPDR Fund for 100 Days and Zeta Global Holdings Corp for 19 Days on average.
| XLV | ZETA | |
|---|---|---|
Market Cap | $43.48B | $8.29B |
Volume | 11,121,431 | 7,156,795 |
52-Week High | $175.68 | $33.74 |
52-Week Low | $141.95 | $14.55 |
Typical Hold Time | 100 Days | 19 Days |
Sector | — | Technology |
Enterprise Value | — | $8.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
XLV trades at $170.81, up 1.18% with a bearish technical signal from moving averages. The ETF's low 0.08% expense ratio and healthcare sector diversification provide defensive positioning amid market volatility. Recent options activity shows increased put volume, indicating some investor caution despite healthcare's traditional defensive characteristics during economic uncertainty.
Healthcare sector ETFs like XLV offer defensive exposure with potential upside from demographic trends and innovation. Key risks include political volatility around healthcare policy and concentration in large-cap US stocks. The ETF's cost efficiency and sector positioning make it attractive for long-term investors seeking healthcare exposure.
ZETA trades at $33.09, down 1.93% today, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and support at $32. Fundamentally, revenue grew to $1.3B in 2025 with a gross margin of 59.48%, but net income remains negative. Recent quarters saw EPS beats, and the company is expanding internationally with a new UK hub. Analyst sentiment is positive with 12 buy ratings and a $32.40 consensus target.
The outlook is cautiously optimistic due to strong revenue growth and AI-driven customer adoption, but profitability risks persist with negative net margins and high valuation multiples. Investors should weigh growth potential against execution risks and competitive pressures in the tech services sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →About Zeta Global Holdings Corp
Zeta Global is a leading data-driven marketing technology company that provides an omnichannel AI Marketing Cloud. By leveraging a proprietary data cloud of over 2.4 billion deterministic identities, it enables enterprise brands to acquire, grow, and retain customers through predictive intelligence and automated, agentic workflows.
Read more on ZETA →
